Biovica International Ownership

BIOVIC-B  SEK 2.17  0.07  3.33%   
Biovica International holds a total of 39.47 Million outstanding shares. Almost 96.27 percent of Biovica International outstanding shares are held by general public with 3.73 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Biovica International in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biovica International, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovica International AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Biovica Stock Ownership Analysis

The book value of the company was currently reported as 2.86. The company recorded a loss per share of 2.11. Biovica International had not issued any dividends in recent years. Biovica International AB , a biotech company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. Biovica International AB was founded in 2009 and is based in Uppsala, Sweden. Biovica International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people. For more info on Biovica International AB please contact Cecilia Driving at 46 1 84 44 48 30 or go to https://www.biovica.com.

Biovica International Outstanding Bonds

Biovica International issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biovica International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biovica bonds can be classified according to their maturity, which is the date when Biovica International AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Biovica Stock

Biovica International financial ratios help investors to determine whether Biovica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovica with respect to the benefits of owning Biovica International security.